Compare MCRB & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCRB | CLAR |
|---|---|---|
| Founded | 2010 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.7M | 129.8M |
| IPO Year | 2015 | N/A |
| Metric | MCRB | CLAR |
|---|---|---|
| Price | $15.04 | $3.74 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $14.33 | $5.33 |
| AVG Volume (30 Days) | 43.7K | ★ 138.4K |
| Earning Date | 03-12-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | $351,000.00 | ★ $256,432,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.85 |
| P/E Ratio | $24.47 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.53 | $3.02 |
| 52 Week High | $29.98 | $5.00 |
| Indicator | MCRB | CLAR |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 58.50 |
| Support Level | $14.41 | $3.49 |
| Resistance Level | $16.12 | $3.92 |
| Average True Range (ATR) | 0.83 | 0.17 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 44.28 | 60.47 |
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.